Molecular targets of lead in brain neurotoxicity

Neurotoxicity Research

Volumn 5, Issue 3, 2003, Pages 221-235

  Marchetti, Carla ^a  

^a CNR   (Italy)

Author keywords

Calcium channels; Glutamate activated channels; Metal uptake; NMDA receptor subunits; Protein kinase C; Synaptic plasticity

Indexed keywords

CALCIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER RECEPTOR; PROTEIN KINASE C;

ANIMAL; BRAIN DISEASE; HUMAN; LEAD POISONING; METABOLISM; REVIEW; TOXICITY AND INTOXICATION;

ANIMALS; BRAIN DISEASES; CALCIUM; HUMANS; LEAD POISONING; NEUROTOXICITY SYNDROMES; PROTEIN KINASE C; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTRANSMITTER;

EID: 0038785843     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033142     Document Type: Review

References (145)

1. Akazawa C, R Shigemoto, Y Bessho, S Nakanishi and N Mizuno (1994) Differential expression of five N-methyl-D-aspartate receptor subunit MRNAs in the cerebellum of developing and adult rats. J. Comp. Neurol. 347, 150-160.
2. Alkondon M, AC Costa, V Radhkrishnan, RS Aronstam and EX Albuquerque (1990) Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett. 261, 124-130.
3. Banks EC, LE Ferretti and DW Shucard (1997) Effects of low level lead exposure on cognitive function in children: A review of behavioral, neuropsychological and biological evidence. Neurotoxicology 18, 237-281.
4. Baranano DE, CD Ferris and SH Snyder (2001) Atypical neural mesengers. Trends Neurosci. 24, 99-106.
5. Bellinger D, J Sloman, A Leviron, M Rabinowitz, HL Needleman and C Waternaux (1991) Low level lead exposure and children's cognitive function in the preschool years. Pediatrics 87, 219-227.
6. ++ channels requires treatment with heavy metal antidotes. J. Pharm. Exp. Ther. 282, 172-180.
7. Bourjeily N and JB Suszkiw (1997) Developmental cholinotoxicity of lead: loss of septal cholinergic neurons and long-term changes in cholinergic innervation of the hippocampus in perinatally lead-exposed rats. Brain Res. 771, 319-328.
8. Bouton CM and J Pevsner (2000) Effects of lead on gene expression. Neurotoxicology 21, 1045-1055.
9. Bouton CM, LP Frelin, CE Forde, H Arnold Godwin and J Pevsner (2001) Synaptotagmin I is a molecular target for lead. J. Neurochem. 76, 1724-1735.
10. Boyce S, A Wyatt, JK Webb, R O'Donnell, G Mason, M Rigby, D Sirinathsinghji, RG Hill and NM Rupniak (1999) Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn, Neuropharmacology 38, 611-623.
11. Bradbury MW and R Deane (1993) Perm eability of the blood-brain barrier to lead. Neurotoxicology 14, 131-136.
12. Braga MF, EF Pereira and EX Albuquerque (1999a) Nanomolar concentrations of lead inhibit glutamatergic and GABA ergic transmission in hippocampal neurons. Brain Res. 826, 22-34.
13. Braga MF, EF Pereira, M Marchioro and EX Albuquerque (1999b) Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. Brain Res. 826, 10-21.
14. Bressler J, KA Kim, T Chakraborti and G Goldstein (1999) Molecular mechanisms of lead neurotoxicity. Neurochem. Res. 24, 595-600.
15. Büsselberg D, ML Evans, HL Haas and DO Carpenter (1993) Blockade of mammalian and invertebrate calcium channels by lead. Neurotoxicology 14, 249-258.
16. 2+ reduces voltage-and N -methyl-D-aspartate (NMDA)-activated calcium channel currents. Cell. Mol. Neurobiol. 14, 711-722.
17. 3+. J. Neurophysiol. 71, 1491-1497.
18. Cai L, DY Ruan, YZ Xu, L Liu, XM Meng and XQ Dai (2001) Effects of lead exposure on long-term potentiation induced by 2-deoxy-D-glucose in area CA1 of rat hippocampus in vitro. Neurotoxicol. Teratol. 23, 481-487.
19. Carpenter DO, MR Matthews, PJ Parsons and N Hori (1994) Longterm potentiation in the piriform cortex is blocked by lead. Cell. Mol. Neurobiol. 14, 723-733.
20. Clarkson T (1993) Molecular and ionic mimicry of toxic metals. Annu. Rev. Pharmacol. Toxicol. 32, 545-571.
21. Clemedson C, M Nordin-Andersson, HF Bjerregaard, J Clausen, A Forsby, H Gustafsson, U Hansson, B Isomaa, C Jorgensen, A Kolman, N Kotova, G Krause, U Kristen, K Kurppa, L Romert and E Scheers (2002) Development of an in vitro test battery for the estimation of acute human systemic toxicity: An outline of the EDIT project. Evaluation-guided Development of New In Vitro Test Batteries. Altern. Lab. Anim. 30, 313-321.
22. Cory-Slechta DA (1995) Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annu. Rev. Pharmacol. Toxicol. 35, 391-415.
23. Cory-Slechta DA (1997) Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity. Neurotoxicology 18, 673-688.
24. Cory-Slechta DA, M Garcia-Osuna and IT Greenamyre (1997) Lead-induced changes in NMDA receptor complex binding: Correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration. Behav. Brain Res. 85, 161-174.
25. Costa LG and DA Fox (1983) A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure. Brain Res. 276, 259-266.
26. Crumpton T, DS Atkins, NH Zawia and S Barone Jr (2001) Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding. Neurotoxicology 22, 49-62.
27. Cull-Candy S, S Brickley and M Farrant (2001) NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol., 11, 327-335.
28. Deane R and MW Bradbury (1990) Transport of lead-203 at the blood-brain barrier during short cerebrovascular perfusion with saline in the rat. J. Neurochem. 54, 905-914.
29. Diaz RS and J Monreal (1995) Protein-independent lead permeation through myelin lipid liposomes. Mol. Pharmacol. 47, 766-771.
30. Dietrich KN, MD Ris, PA Succop, OG Berger and RL Bornschein (2001) Early exposure to lead and juvenile delinquency. Neurotoxicol. Teratol. 23, 511-518.
31. Dingledine R, K Borges, D Bowie and SF Traynelis (1999) The glutamate receptor ion channels. Pharm. Rev. 51, 7-61.
32. Dyatlov VA, OM Dyatlova, PJ Parsons, DA Lawrence and DO Carpenter (1998) Lipopolysaccharide and interleukin-6 enhance lead entry into cerebellar neurons: Application of a new and sensitive flow cytometric technique to measure intracellular lead and calcium concentrations. Neurotoxicology 19, 293-302.
33. Farrant M, D Feldmeyer, T Takahashi and SG Cull-Candy (1994) NMDA-receptor channel diversity in the developing cerebellum. Nature 368, 335-339.
34. Finkelstein Y, ME Markowitz and JF Rosen (1998) Low-level lead-induced neurotoxicity in children: An update on central nervous system effects. Brain Res. Brain Res. Rev. 27, 168-176.
35. Gavazzo P, A Gazzoli, M Mazzolini and C Marchetti (2001) Lead inhibition of NMDA channels in native and recombinant receptors. Neuroreport 12, 3121-3125.
36. Gilbert ME, CM Mack and SM Lasley (1996) Chronic developmental lead exposure increases the threshold for long-term potentiation in rat dentate gyrus in vivo. Brain Res. 736, 118-124.
37. Gilbert ME, CM Mack and SM Lasley (1999) The influence of developmental period of lead exposure on long-term potentiation in the adult rat dentate gyrus in vivo. Neurotoxicology 20, 57-69.
38. Goldstein GW (1993) Evidence that lead acts as a calcium substitute in second messenger metabolism. Neurotoxicology 14, 97-101.
39. Grant SG and TJ O'Dell (2001) Multiprotein complex signaling and the plasticity problem. Curr. Opin. Neurobiol. 11, 363-368.
40. 2+ in trigeminal neurons. J. Neurosci. 14, 4561-4570.
41. Guilarte TR (1997a) Glutamatergic system and developmental lead neurotoxicity. Neurotoxicology 18, 665-672.
42. 2+ inhibits NMDA receptor function at high and low affinity sites: Developmental and regional brain expression. Neurotoxicology 18, 43-52.
43. Guilarte TR and JL McGlothan (1998) Hippocampal NMDA receptor mRNA undergoes subunit specific changes during developmental lead exposure. Brain Res. 790, 98-107.
44. Guilarte TR and RC Miceli (1992) Age-dependent effects of lead on [3H]MK-801 binding to the NMDA receptor-gated ionophore: In vitro and in vivo studies. Neurosci. Lett. 148, 27-30.
45. 2+ exposure increases [3 H]MK801 binding sites in adult rat forebrain. Eur. J. Pharmacol. 248, 273-275.
46. Guilarte TR, RC Miceli and DA Jett (1995) Biochemical evidence of an interaction of lead at the zinc allosteric sites of the NMDA receptor complex: Effects of neuronal development. Neurotoxicology 16, 63-71.
47. Guilarte TR, JL McGlothan and MK Nihei (2000) Hippocampal expression of N -methyl-D-aspartate receptor (NMDAR1) subunit splice variant mRNA is altered by developmental exposure to Pb(2+). Brain Res. Mol. Brain Res. 76, 299-305.
48. Gutowski M, L Altmann, K Sveinsson and H Wiegand (1998) Synaptic plasticity in the CA1 and CA3 hippocampal region of pre- and postnatally lead-exposed rats. Toxicol. Lett. 95, 195-203.
49. Hanas JS, JS Rodgers, JA Bantle and YG Cheng (1999) Lead inhibition of DNA-binding mechanism of Cys(2)His(2) zinc finger proteins. Mol. Pharmacol. 56, 982-988.
50. Hartwig A (2001) Zinc finger proteins as potential targets for toxic metal ions: Differential effects on structure and function. Antioxid. Redox Signal 3, 625-634.
51. Hashemzadeh-Gargari H and TR Guilarte (1999) Divalent cations modulate N-methyl-D-aspartate receptor function at the glycine site. J. Pharm. Exp. Ther. 290, 1356-1362.
52. Hoffmann H, T Gremme, H Hatt and K Gottmann (2000) Synaptic activity-dependent development regulation of NMDA receptor subunit expression in cultured neocortical neurons. J. Neurochem. 75, 1590-1599.
53. Holme JA and E Dybing (2002) The use of in vitro methods for hazard characterisation of chemicals. Toxicol. Lett. 127, 135-141.
54. Hori N, D Busselberg, MR Matthews, PJ Parsons and DO Carpenter (1993) Lead blocks LTP by an action not at NMDA receptors. Exp. Neurol. 119, 192-197.
55. Hossain MA, CM Bouton, J Pevsner and J Laterra (2000) Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway. J. Biol. Chem. 275, 27874-27882.
56. Husi H, MA Ward, JS Choudhary, WP Blackstock and SG Grant (2000) Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nature Neurosci. 3, 661-669.
57. Ishihara K, M Alkondon, JG Montes and EX Albuquerque (1995) Ontogenically related properties of N -methyl-D-aspartate receptors in rat hippocampal neurons and the age-specific sensitivity of developing neurons to lead. J. Pharm. Exp. Ther. 273, 1459-1470.
58. Jadhav AL and GT Ramesh (1997) Pb-induced alterations in tyrosine hydroxylase activity in rat brain. Mol. Cell. Biochem. 175, 137-141.
59. Jett DA, AC Kuhlmann, SJ Farmer and TR Guilarte (1997) Agedependent effects of developmental lead exposure on performance in the Morris water maze. Pharmacol. Biochem. Behav. 57, 271-279.
60. Johnston MV and GW Goldstein (1998) Selective vulnerability of the developing brain to lead. Curr. Opin. Neurol. 11, 689-693.
61. Kern M, M Wisniewski, L Cabell and G Audesirk (2000) Inorganic lead and calcium interact positively in activation of calmodulin. Neurotoxicology 21, 353-363.
62. Kerper LE and PM Hinkle (1997a) Cellular uptake of lead is activated by depletion of intracellular calcium stores. J. Biol. Chem. 272, 8346-8352.
63. Kerper LE and PM Hinkle (1997b) Lead uptake in brain capillary endothelial cells: Activation by calcium store depletion. Toxicol. Appl. Pharmacol. 146, 127-133.
64. Kew JN, JG Richards, V Mutel and JA Kemp (1998) Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J. Neurosci. 18, 1935-1943.
65. Kim KA, T Chakraborti, GW Goldstein and JP Bressler (2000) Immediate early gene expression in PC12 cells exposed to lead: Requirement for protein kinase C. J. Neurochem. 74, 1140-1146.
66. Kim KA, T Chakraborti, G Goldstein, M Johnston and J Bressler (2002) Exposure to lead elevates induction of zif268 and Arc mRNA in rats after electroconvulsive shock: The involvement of protein kinase C. J. Neurosci. Res. 69, 268-277.
67. Kivalo P, R Virtanen, K Wickstrom and M Wilson (1976) An evaluation of some commercial lead(II)-selective electrodes. Analytica Chimica Acta 87, 401-409.
68. Krupp JJ, B Vissel, SF Heinemann and GL Westbrook (1996) Calcium-dependent inactivation of recombinant N -methyl-D-aspartate receptors is NR2 subunit specific. Mol. Pharmacol. 50, 1680-1688.
69. Kuhlmann AC, JL McGlothan and TR Guilarte (1997) Developmental lead exposure causes spatial learning deficits in adult rats. Neurosci. Lett. 233, 101-104.
70. Lasley SM and ME Gilbert (1996) Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead. Brain Res. 736, 125-134.
71. Lasley SM and ME Gilbert (1999) Lead inhibits the rat N -methyl-D-aspartate receptor channel by binding to a site distinct from the zinc allosteric site. Toxicol. Appl. Pharmacol. 159, 224-233.
72. Lasley SM and ME Gilbert (2000) Glutamatergic components under-lying lead-induced impairments in hippocampal synaptic plasticity. Neurotoxicology 21, 1057-1068.
73. Lasley SM and ME Gilbert (2002) Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chronic lead exposure level. Toxicol. Sci. 66, 139-147.
74. Lasley SM, J Polan-Curtain and DL Armstrong (1993) Chronic exposure to environmental levels of lead impairs in vivo induction of long-term potentiation in rat hippocampal dentate. Brain Res. 614, 347-351.
75. Lasley SM, MC Green and ME Gilbert (2001) Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicol. Teratol. 23, 185-189.
76. Lau WK, CW Yeung, PW, Lui, LH Cheung, NT Poon and KK Yung (2002) Different trends in modulation of NMDAR1 and NMDAR2B gene expression in cultured cortical and hippocampal neurons after lead exposure. Brain Res. 932, 10-24.
77. 2+ entry into cultured astroglia. Toxicol. Sci. 46, 90-100.
78. Lim DK and IK Ho (1998) Responses to N -methyl-D-aspartate and kainic acid in cerebellar granule cells of lead-exposed rat pups. Neurotoxicology 19, 49-55.
79. Lindahl LS, L Bird, ME Legare, G Mikeska, GR Bratton and E Tiffany-Castiglioni (1999) Differential ability of astroglia and neuronal cells to accumulate lead: Dependence on cell type and on degree of differentiation. Toxicol. Sci. 50, 236-243.
80. Linden AM, J Vasanen, M Storvik, M Lakso, ER Korpi, G Wong and E Castren (2001) Uncompetitive antagonists of the N -methyl-D-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex. Pharmacol. Toxicol. 88, 98-105.
81. Long GJ, JF Rosen and FA Schanne (1994) Lead activation of protein kinase C from rat brain. Determmation of free calcium, lead, and zinc by 19 F NMR. J. Biol. Chem. 269, 834-837.
82. Losi G, K Prybylowski, Z Fu, Jh Luo and S Vicini (2002) Silent synapses in developing cerebellar granule neurons. J Neurophysiol. 87, 1263-1270.
83. 2+ on expression of acetylcholinesterase and the acetylcholine receptor. Toxicol. Appl. Pharmacol. 145, 237-245.
84. Ma T, HH Chen, HL Chang, AS Hume and IK Ho (1997a) Effects of chronic lead exposure on [3 H]MK-801 binding in the brain of rat. Toxicol. Lett. 92, 59-66.
85. Ma T, HH Chen, DK Lim, AS Hume and IK Ho (1997b) Effects of subacute lead exposure on [3 H]MK-801 binding in hippocampus and cerebral cortex in the adult rat. Brain Res. 760, 187-192.
86. Markovac J and GW Goldstein (1988) Picomolar concentrations of lead stimulate brain protein kinase C. Nature 334, 71-73.
87. Markowitz M (2000) Lead poisoning: A disease for the next millennium, Curr. Probl. Pediatr. 30, 62-70.
88. Matthews MR, PJ Parsons and DO Carpenter (1993) Solubility of lead as lead (II) chloride in HEPES-Ringer and artificial seawater (Ca-ASW) solutions. Neurotoxicology 14, 283-290.
89. 2+ permeation in rat cerebellar granule neurones. J. Neurochem. 79, 407-416.
90. Monyer H, N Burnashev, DJ Laurie, B Sakmann and PH Seeburg (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
91. Morgan RE, H Garavan, EG Smith, LL Driscoll, DA Levitsky and BJ Strupp (2001) Early lead exposure produces lasting changes in sustained attention, response initiation, and reactivity to errors. Neurotoxicol. Teratol. 23, 519-531.
92. Murakami K, G Feng and SG Chen (1993) Inhibition of brain protein kinase C subtypes by lead. J. Pharm. Exp. Ther. 264, 757-761.
93. Murphy KJ and CM Regan (1999) Low-level lead exposure in the early postnatal period results in persisting neuroplastic deficits associated with memory consolidation. J. Neurochem. 72, 2099-2104.
94. Needleman HL (1993) The current status of childhood low-level lead toxicity. Neurotoxicology 14, 161-166.
95. Nehru B and P Sidhu (2001) Behavior and neurotoxic consequences of lead on rat brain followed by recovery. Biol. Trace. Elem. Res. 84, 113-121.
96. 2+ during development. Brain. Res. Mol. Brain. Res. 66, 42-49.
97. 2+: Association with deficits of LTP and spatial learning. Neurotoxicology 22, 635-643.
98. Nihei MK, NL Desmond, JL McGlothan, AC Kuhlmann and TR Guilarte (2000) N -methyl-D-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning. Neuroscience 99, 233-242.
99. Omelchenko IA, CS Nelson, JL Marino and CN Allen (1996) The sensitivity of N -methyl-D-aspartate receptors to lead inhibition is dependent on the receptor subunit composition. J. Pharm. Exp. Ther. 278, 15-20.
100. Omelchenko IA, CS Nelson and CN Allen (1997) Lead inhibition of N -methyl-D-aspartate receptors containing NR2A, NR2C and NR2D subunits. J. Pharm. Exp. Ther. 282, 1458-1464.
101. 2+. Neuron 15, 1109-1120.
102. Paoletti P, P Ascher and J Neyton (1997) High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J. Neurosci. 17, 5711-5725.
103. Paoletti P, F Perin-Dureau, A Fayyazuddin, A Le Goff, I Callebaut and J Neyton (2000) Molecular organization of a zinc binding N -terminal modulatory domain in a NMDA receptor subunit. Neuron 28, 911-925.
104. Reuhl KR, DC Rice, SG Gilbert and J Mallett (1989) Effects of chronic developmental lead exposure on monkey neuroanatomy: Visual system. Toxicol. Appl. Pharmacol. 99, 501-509.
105. Rogan WJ, KN Dietrich, JH Ware, DW Dockery, M Salganik, J Radcliffe, RL Jones, NB Ragan, JJ Chisolm Jr and GG Rhoads (2001) The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N. Engl. J. Med. 344, 1421-1426.
106. Ruan DY, JT Chen, C Zhao, YZ Xu, M Wang and WF Zhao (1998) Impairment of long-term potentiation and paired-pulse facilitation in rat hippocampal dentate gyrus following developmental lead exposure in vivo. Brain Res. 806, 196-201.
107. Schulte S, WE Muller and KD Friedberg (1995) In vitro and in vivo effects of lead on specific 3 H-MK-801 binding to NMDA-receptors in the brain of mice. Neurotoxicology 16, 309-317.
108. Simons TJ (1985) Influence of lead ions on cation permeability in human red cell ghosts. J. Membr. Biol. 84, 61-71.
109. Simons TJ (1986) The role of anion transport in the passive movement of lead across the human red cell membrane J. Physiol. (Lond) 378, 287-312.
110. Simons TJ (1993a) Lead-calcium interactions in cellular lead toxicity. Neurotoxicology 14, 77-85.
111. Simons TJ (1993b) Lead, transport and binding by human erythrocytes in vitro. Pflugers Arch. Pharmacol. 423, 307-313.
112. Simons TJ and G Pocock (1987) Lead enters bovine adrenal medullary cells through calcium channels. J. Neurochem. 48, 383-389.
113. Smith QR, O Rabin and EG Chikhale (1997) Deliver of metals to brain and the role of the blood-brain barrier, In: Connor JR (Ed), Metals and Oxidative Damage in Neurological Disorders (Plenum Press, New York and London), pp. 113-130.
114. Stewart PW, V Delbagno, J Ng, R Burright and P Donovick (1998) Subacute Pb exposure during development and unbaited tunnel maze performance in mice. Pharmacol. Biochem. Behav. 59, 183-189.
115. Stiles KM and DC Bellinger (1993) Neuropsychological correlates of low-level lead exposure in school-age children: A prospective study. Neurotoxicol. Teratol. 15, 27-35.
116. Struzynska I, M Walski, R Gadamski, B Dabrowska-Bouta and U Rafalowska (1997) Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol. Chem. Neuropathol. 31, 207-224.
117. Suen PC, K Wu, JL Xu, SY Lin, ES Levine and IB Black (1998) NMDA receptor subunits in the postsynaptic density of rat brain: Expression and phosphorylation by endogenous protein kinases. Brain Res. Mol. Brain Res. 59, 215-228.
118. Sui L, SY Ge, DY Ruan, JT Chen, YZ Xu and M Wang (2000a) Agerelated impairment of long-term depression in area CA1 and dentate gyrus of rat hippocampus following developmental lead exposure in vitro. Neurotoxicol. Teratol. 22, 381-387.
119. Sui L, DY Ruan, SY Ge and XM Meng (2000b) Two components of long-term depression are impaired by chronic lead exposure in are CA1 and dentate gyrus of rat hippocampus in vitro. Neurotoxicol. Teratol. 22, 741-749.
120. 2+ on protein kinase C isozymes. Toxicol. Appl. Pharmacol. 156, 40-45.
121. Tavakoli-Nezhad M, AJ Barron and DK Pitts (2001) Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat. Neurotoxicology 22, 259-269.
122. Tiffany-Castiglion E and Y Qian (2001) Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 22, 577-592.
123. 2+. Am. J. Physiol. 259, C762-C768.
124. 2+ entry in isolated bovine chromaffin cells. Biochem. Biophys. Acta 1069, 197-200.
125. 2+ -induced norepinephrine release from bovine chromaffin cells. Am. J. Physiol. 265, C1630-C1636.
126. 2+ and protein kinase C and its role in norepineph rine release from bovine adrenal chromaffin cells. J. Neurochem. 64, 2667-2673.
127. Toni N, PA Buchs, I Nikonenko, CR Bron and D Muller (1999) LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402, 421-425.
128. Ujihara H and EX Albuquerque (1992) Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons. J. Pharm. Exp. Ther. 263, 868-875.
129. Usai C, A Barberis, L Moccagatta and C Marchetti (1999) Pathways of cadmium influx in mammalian neurons. J. Neurochem. 72, 2154-2161.
130. Wang LY and JF MacDonald (1995) Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones. J. Physiol. 486, 83-95.
131. Weast R (1977) Handbook of Physical Chemistry (CRC Press: Cleveland, OH), pp. F213-F214.
132. Wenzel A, JM Fritschy, H Mohler and D Benke (1997) NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68, 469-478.
133. 2+. J. Neurochem. 80, 861-873.
134. White RF, R Diamond, S Proctor, C Morey and H Hu (1993) Residual cognitive deficits 50 years after lead poisoning during childhood. Br. J. Ind. Med. 50, 613-622.
135. Widzowski DV and DA Cory-Slechta (1994) Homogeneity of regional brain lead concentrations. Neurotoxicology 15, 295-307.
136. 2+ reduces the current from NMDA receptors expressed in Xenopus oocytes. FEBS Lett. 377, 390-392.
137. Yeh GC, DW Bonhaus and JO McNamara (1990) Evidence that zinc inhibits N -methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding. Mol. Pharmacol. 38, 14-19.
138. Yi EY and DK Lim (1998) Effects of chronic lead exposure on glutamate release and uptake in cerebellar cells of rat pups. Arch. Pharm. Res. 21, 113-119.
139. Zawia NH, T Crumpton, M Brydie, GR Reddy and M Razmiafshari (2000) Disruption of the zinc finger domain: A common target that underlies many of the effects of lead. Neurotoxicology 21, 1069-1080.
140. Zhang XY, AP Liu, DY Ruan and J Liu (2002) Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry., Neurotoxicol. Teratol. 24, 149-160.
141. Zhao WF, DY Ruan, YZ Xu, JT Chen, M Wang and SY Ge (1999) The effects of chronic lead exposure on long-term depression in area CA1 and dentate gyrus of rat hippocampus in vitro. Brain Res. 818, 153-159.
142. Zheng W (2001) Toxicology of choroid, plexus: Special reference to metal-induced neurotoxicities. Microsc. Res. Tech. 52, 89-103.
143. Zheng W, WS Blaner and Q Zhao (1999) Inhibition by lead of production and secretion of transthyretin in the choroid plexus: Its relation to thyroxine transport at blood-CSF barrier. Toxicol. Appl. Pharmacol. 155, 24-31.
144. Zheng W, YM Lu, GY Lu, Q Zhao, O Cheung and WS Blaner (2001) Transthyretin, thyroxine, and retinol-binding protein in human cerebrospinal fluid: Effect of lead exposure. Toxicol. Sci. 61, 107-114.
145. Zheng W, H Shen, WS Blaner, Q Zhao, X Ren and JH Graziano (1996) Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid: The role of the choroid plexus. Toxicol. Appl. Pharmacol. 139, 445-450.